MEVET SAU, headquartered in Lleida, Spain, is a specialized veterinary pharmaceutical laboratory focused on the development, manufacture, and commercialization of products aimed at improving the health and performance of livestock. As part of the Grupo Vall Companys, one of Spain’s largest integrated agri-food groups, MEVET benefits from robust infrastructure, scientific expertise, and vertical integration across the animal production chain.
Core Business
MEVET SAU operates in the veterinary pharmaceuticals and animal health domain with a core mission to provide:
- Therapeutic veterinary pharmaceuticals
- Preventive health solutions
- Nutritional feed additives
- Farm biosecurity products
The company addresses both curative and preventive needs for swine, poultry, and ruminant sectors.
Product & Service Offerings
MEVET maintains a diverse and targeted product portfolio for veterinary professionals and integrators.
Disinfectants
- A full range of biosecurity solutions tailored for different farm environments and animal species, including bactericidal, virucidal, and fungicidal agents.
Feed Supplements
- Nutritional additives and performance enhancers that support animal growth, gut health, and stress resilience. Used widely in intensive farming systems.
Medicated Premixes
- Premixes with therapeutic agents incorporated into feed for mass treatment and prevention of common diseases in swine and poultry.
Oral Formulations
- Liquid suspensions and water-soluble powders designed for mass administration via drinking water systems, allowing efficient and stress-free dosing.
Injectable Formulations
- Sterile injectable solutions used for acute infections, metabolic disorders, and reproductive health across all major livestock species.
Specialization and Unique Selling Proposition (USP)
MEVET SAU’s unique strengths include:
- Close integration with Grupo Vall Companys, providing real-time insight into production-level challenges and outcomes
- R&D-led product development supported by in-field trial data and laboratory validation
- Focus on biosecurity, antimicrobial stewardship, and precision dosing
- Strong regulatory and GMP compliance, enabling export to multiple international markets
Financials and Business Growth
As a subsidiary of Grupo Vall Companys, MEVET does not publicly disclose standalone financials. However:
- Grupo Vall Companys reports annual revenues of over €2 billion
- MEVET contributes to the veterinary pharmaceuticals vertical that supports millions of animals annually across integrated farms
- Consistent product line expansions in oral and injectable formulations
Shipment Records
According to available trade intelligence:
- MEVET SAU has completed over 75 international shipments since 2020
- Active export markets include Portugal, Poland, Mexico, Morocco, and Egypt
- Top exported product categories include medicated premixes and oral suspensions
Target Market
MEVET targets key players in the livestock and animal health ecosystem:
- Veterinary clinics and professionals
- Animal integrators and large-scale producers
- Feed manufacturers and nutritionists
- Distributors of veterinary pharmaceuticals
- Biosecurity consultants and farm managers
Capabilities
- GMP-certified production facilities for injectables, liquids, and powders
- In-house R&D and laboratory services
- Regulatory affairs team for product registration in EU and non-EU countries
- Pharmacovigilance systems to ensure continuous product safety monitoring
Certifications and Compliance
- GMP certification by Spanish health authorities
- Compliance with EU veterinary pharmaceutical standards
- Adheres to EMA (European Medicines Agency) and AEMPS (Spanish Agency for Medicines and Health Products) regulations
- Operates within the One Health framework, aligning with antimicrobial resistance (AMR) reduction strategies
Customer Testimonials
“MEVET’s oral formulations are not only effective but also palatable and easy to administer at scale. We’ve improved treatment compliance significantly.”
— Head of Livestock Operations, Integrated Poultry Producer, Spain
“Their biosecurity range has been pivotal in controlling disease pressure on our multi-site pig farms.”
— Farm Manager, Swine Producer, Portugal
Major Achievements
- Integral part of the Vall Companys Group, managing more than 9 million pigs and 200 million poultry annually
- Expanded product portfolio to meet evolving regulatory and resistance challenges
- Ongoing collaborations with veterinary universities and field researchers across Spain
- Recognized within the Spanish veterinary community for technical innovation and operational support
MEVET SAU combines scientific rigor with practical farm experience, offering veterinary solutions that are effective, safe, and tailored to modern animal production systems. Its commitment to quality, biosecurity, and responsible medication continues to make it a trusted partner across the global animal health landscape.
